$30.53
2.147.54%
Últ. Act.: Nov 6, 7:34 PM
The average analyst price target for Immunovant is $41.88, 43.9% above the current price. Of 14 analysts, 11 rate it Buy and 3 Hold. Targets range from $17 to $62. The latest change came on Aug 4, 2026, when JP Morgan raised its price target on Immunovant from $47 to $50 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months